1VERANI J R, MCGEE L, SCHRAG S J. Prevention of Perinatal Group B Streptococcal Disease-revised guidelines from CDC, 2010 [R]. MMWR Recomm Rep, 2010,59(RR-10) :1-36.
2GILBERT R. Prenatal screening for group B streptococcal in- fection: gaps in the evidence[J]. Int J Epidemiol, 2004, 33 (1) :2-8.
3SHET A, FERRIERI P. Neonatal & maternal group B strep- tococcal infections: a comprehensive review[J]. Indian J Med Res, 2004,120(3) :141-150.
4FRANCIOSI R A, KNOSTMAN J D, ZIMMERMAN R A. Group B streptococcal neonatal and infant infections[J]. J Pe- diatr, 1973,82(4) :707-718.
5SCHRAG S J, ZYWICKI S, FARLEY M M, et al. Group B streptococcal disease in the era of intrapartum antibiotic pro- phylaxis[J]. N Engl J Med, 2000,342(1) :15-20.
6PHARES C R, LYNFIELD R, FARLEY M M, et al. Epide- miology of invasive group B streptococcal disease in the United States, 1999-2005[J]. JAMA, 2008,299(17) :2056-2065.
7DESA D J, TREVENEN C L. Intrauterine infections with group B beta-haemolytic streptoeocci[J]. Br J Obstet Gynae- col, 1984,91(3) :237-239.
8KATZ V, BOWES W A. Perinatal group B streptococcal infec- tions across intact amniotic membranes[J]. J Reprod Med, 1988,33(5) :445-449.
9JOHRI A K, PAOLETTI L C, GLASER P, et al. Group B streptococcus: global incidence and vaccine development [J]. Nat Rev Mierobiol, 2006,4(12) :932-942.
10SCHUCHAT A. Epidemiology of group B streptococcal di-sease in the United States: shifting paradigms[J]. Clin Micro- biol Rev, 1998,11(3) :497-513.
9Hager W D, Schuchat A, Gibbs R, et al. Prevention of perinatal group B streptococcal infection: current controversies. Obstet Gynecol, 2000, 96:141- 145.
10Centers for Disease Control and Prevention, Division of Bacterial and Mycotic Diseases. Group B Streptococcal Disease. Available at: http..//www, cdc. gov/neidod/dbmd/ diseaseinfo/groupbstrep_g, htm. Accessed October 27, 2002.
